Morgan Stanley Reiterates Equal-Weight on Hospira

Emily Austin , Benzinga Staff Writer

July 05, 2011 7:39am Comments

Morgan Stanley reiterated its Equal-Weight rating on Hospira (NYSE: HSP). At the moment, Morgan Stanley does not have a price target on the company's stock. On Friday, Hospira lost 1.75% of its value to end the week at $55.67.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: Hospira Morgan Stanley Reiteration Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

View the Latest Analytics Ratings

1	XLK, QQQ: This Nasdaq 100 Signal Last Flashed In 1999—What Came Next Was Insane
2	QQQ, SPY: Federal Reserve Rates 'Justified' Despite Being Highes...
3	KO: Coke's Sweet Switch: Cane Sugar Beverage, Fairlife Ramp O...
4	IVZ, DIA: Lockheed, General Motors Tumble, Gold Hits 1-Month Hig...
5	HON: Honeywell Lifts Outlook As Transformation Picks Up Speed
6	THRM: Uncovering Potential: Gentherm's Earnings...
7	CLF: Cleveland-Cliffs Rides Cost Cuts And Trump T...

1	Her Husband Believes The Government Isn't Real And That They Don't Hav...
2	NVO: Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Las...
3	MASI: $1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
4	GOOGL, GOOG: Google Stock Roars As Analysts Race To Raise Price Targets
5	$BTC, DJT: Trump Media (DJT) Stock Pulls Back, Consolidating Rec...
6	GSK: GSK's Blood Cancer Drug Review Extended As FD...
7	A New Obesity Contender From China Targeting Same...

Market Overview

Tickers

Articles

Keywords

Morgan Stanley Reiterates Equal-Weight on Hospira

Related Articles (HSP)

Latest Ratings